Department of Rehabilitation Medicine, Erasmus MC, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands.
Rijndam Rehabilitation, 3015 LJ Rotterdam, The Netherlands.
Sensors (Basel). 2023 Jun 25;23(13):5868. doi: 10.3390/s23135868.
This study aims to evaluate the feasibility and explore the efficacy of the Arm Activity Tracker (AAT). The AAT is a device based on wrist-worn accelerometers that provides visual and tactile feedback to stimulate daily life upper extremity (UE) activity in stroke patients.
A randomised, crossover within-subject study was conducted in sub-acute stroke patients admitted to a rehabilitation centre. Feasibility encompassed (1) adherence: the dropout rate and the number of participants with insufficient AAT data collection; (2) acceptance: the technology acceptance model (range: 7-112) and (3) usability: the system usability scale (range: 0-100). A two-way ANOVA was used to estimate the difference between the baseline, intervention and control conditions for (1) paretic UE activity and (2) UE activity ratio.
Seventeen stroke patients were included. A 29% dropout rate was observed, and two participants had insufficient data collection. Participants who adhered to the study reported good acceptance (median (IQR): 94 (77-111)) and usability (median (IQR): 77.5 (75-78.5)-). We found small to medium effect sizes favouring the intervention condition for paretic UE activity (ηG = 0.07, = 0.04) and ratio (ηG = 0.11, = 0.22).
Participants who adhered to the study showed good acceptance and usability of the AAT and increased paretic UE activity. Dropouts should be further evaluated, and a sufficiently powered trial should be performed to analyse efficacy.
本研究旨在评估 Arm Activity Tracker(AAT)的可行性并探索其疗效。AAT 是一种基于腕戴加速度计的设备,通过视觉和触觉反馈刺激脑卒中患者日常生活中的上肢(UE)活动。
一项在康复中心收治的亚急性期脑卒中患者中进行的随机、交叉、自身对照研究。可行性包括(1)依从性:脱落率和 AAT 数据采集不足的参与者人数;(2)接受度:技术接受模型(范围:7-112)和(3)可用性:系统可用性量表(范围:0-100)。采用双向方差分析估计基线、干预和对照条件下(1)患侧 UE 活动和(2)UE 活动比的差异。
共纳入 17 例脑卒中患者。观察到 29%的脱落率,有 2 名参与者的数据采集不足。坚持研究的参与者报告了良好的接受度(中位数(IQR):94(77-111))和可用性(中位数(IQR):77.5(75-78.5))。我们发现干预条件下患侧 UE 活动(ηG = 0.07, = 0.04)和比值(ηG = 0.11, = 0.22)的效果大小为小到中等。
坚持研究的参与者对 AAT 的接受度和可用性较好,且患侧 UE 活动增加。应进一步评估脱落者,并进行足够功率的试验来分析疗效。